A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in
combination with standard of care chronic obstructive pulmonary disease (COPD) maintenance
therapy in patients with COPD who are former or current smokers and have a history of
frequent exacerbations.